{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:08:08Z","timestamp":1790737688795,"version":"4.1.0"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.tranon.2022.101579","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:58:02Z","timestamp":1667264282000},"page":"101579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6342-4842","authenticated-orcid":false,"given":"Luis Alberto","family":"Bravo-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-4936","authenticated-orcid":false,"given":"Natalia","family":"Fr\u00edas-Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-7034","authenticated-orcid":false,"given":"Ana Gabriela","family":"Ramos-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda Madeline","family":"Osorio-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hania Ruth","family":"Zlotnik-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-7261","authenticated-orcid":false,"given":"Sujay","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2022.101579_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2022.101579_bib0002","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2022.101579_bib0003","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","article-title":"Burden of pancreatic cancer: from epidemiology to practice","volume":"19","author":"Khalaf","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tranon.2022.101579_bib0004","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.semcancer.2021.05.030","article-title":"Curing pancreatic cancer","volume":"76","author":"Traub","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015682","article-title":"Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study","volume":"7","author":"Mills","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.tranon.2022.101579_bib0006","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.tranon.2022.101579_bib0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PPO.0000000000000290","article-title":"Diagnosis and detection of pancreatic cancer","volume":"23","author":"Chu","year":"2017","journal-title":"Cancer J."},{"key":"10.1016\/j.tranon.2022.101579_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/jpm11020127","article-title":"Current state of \u201cOmics\u201d biomarkers in pancreatic cancer","volume":"11","author":"Turanli","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0009","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.3748\/wjg.v27.i26.4045","article-title":"Biomarkers in the diagnosis of pancreatic cancer: are we closer to finding the golden ticket?","volume":"27","author":"O'Neill","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2022.101579_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/15384047.2021.1941584","article-title":"Biomarkers for early detection of pancreatic cancer\u2013miRNAs as a potential diagnostic and therapeutic tool?","volume":"22","author":"Tarasiuk","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100965","article-title":"Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer","volume":"14","author":"Iovanna","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0012","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MPA.0000000000001025","article-title":"Quality of life in patients with pancreatic cancer and their caregivers: a systematic review","volume":"47","author":"Bauer","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.tranon.2022.101579_bib0013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pan.2017.01.008","article-title":"Anxiety, depression and quality of life in people with pancreatic cancer and their carers","volume":"17","author":"Janda","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.tranon.2022.101579_bib0014","first-page":"471","article-title":"Quality of life, fatigue, and sleep problems in pancreatic cancer patients-a randomized trial on the effects of exercise","volume":"116","author":"Steindorf","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.tranon.2022.101579_bib0015","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.tranon.2022.101579_bib0016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","article-title":"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer","volume":"21","author":"Yurgelun","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0017","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100634","article-title":"A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition","volume":"296","author":"Horn","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2022.101579_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12885-019-6284-y","article-title":"MicroRNAs in pancreatic cancer: biomarkers, prognostic, and therapeutic modulators","volume":"19","author":"Daoud","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0021","first-page":"306","article-title":"Update on pancreatic intraepithelial Neoplasia","volume":"1","author":"Hruban","year":"2008","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.tranon.2022.101579_bib0022","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","article-title":"Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications","volume":"42","author":"Hu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tranon.2022.101579_bib0023","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcmgh.2021.07.014","article-title":"Uncertain beginnings: acinar and ductal cell plasticity in the development of pancreatic cancer","volume":"13","author":"Grimont","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tranon.2022.101579_bib0024","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7150\/ijms.32751","article-title":"Expression of chosen carcinoembryonic-related cell adhesion molecules in pancreatic intraepithelial neoplasia (PanIN) associated with chronic pancreatitis and pancreatic ductal adenocarcinoma (PDAC)","volume":"16","author":"Zi\u0144czuk","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0025","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.3748\/wjg.v27.i36.6004","article-title":"Histone methylation in pancreatic cancer and its clinical implications","volume":"27","author":"Liu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2022.101579_bib0026","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/biom11081082","article-title":"Epigenetic alterations in pancreatic cancer metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2022.101579_bib0027","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/s12885-022-09863-z","article-title":"Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0028","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/cancers13051071","article-title":"Diagnostic, predictive and prognostic molecular biomarkers in pancreatic cancer: an overview for clinicians","volume":"13","author":"Giannis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10555-020-09952-0","article-title":"An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression","volume":"40","author":"Khan","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.tranon.2022.101579_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/or.2020.7832","article-title":"Methylation of the miR-29b-3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer","volume":"45","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0031","article-title":"N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2\/MYC axis","author":"Peng","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.tranon.2022.101579_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110813","article-title":"SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0033","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1080\/15384101.2021.1991122","article-title":"M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p\/VEGFA\/Akt signaling","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2022.101579_bib0034","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.molmed.2021.07.001","article-title":"Cell-free circulating tumor DNA profiling in cancer management","volume":"27","author":"Roy","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0035","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep4.1918","article-title":"A multi-analyte cell-free DNA\u2013based blood test for early detection of hepatocellular carcinoma","volume":"6","author":"Lin","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tranon.2022.101579_bib0036","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","article-title":"Diagnostic power of DNA methylation classifiers for early detection of cancer","volume":"6","author":"Roy","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0037","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/ph14070677","article-title":"Hacking pancreatic cancer: present and future of personalized medicine","volume":"14","author":"Di Federico","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tranon.2022.101579_bib0038","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3390\/cancers14102429","article-title":"Immunotherapy in pancreatic cancer: why do we keep failing? A focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes","volume":"14","author":"Di Federico","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0039","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4251\/wjgo.v12.i12.1456","article-title":"Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: a case report","volume":"12","author":"Di Marco","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0040","doi-asserted-by":"crossref","first-page":"e16731","DOI":"10.1200\/JCO.2020.38.15_suppl.e16731","article-title":"Intraoperative electrochemotherapy in locally advanced pancreatic cancer: results and impact on quality of life. a single center experience","volume":"38","author":"Di Marco","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0041","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12885-021-08380-9","article-title":"Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0042","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0043","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gutjnl-2016-312539","article-title":"Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?","volume":"66","author":"Hessmann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.tranon.2022.101579_bib0044","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13148-019-0728-8","article-title":"Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis","volume":"11","author":"Natale","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tranon.2022.101579_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111914","article-title":"Emerging roles of miRNAs in the development of pancreatic cancer","volume":"141","author":"Fathi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2022.101579_bib0046","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10555-021-09995-x","article-title":"Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer","volume":"40","author":"Sempere","year":"2021","journal-title":"Cancer Metastas. Rev."},{"key":"10.1016\/j.tranon.2022.101579_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188423","article-title":"The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential","volume":"1874","author":"Pandya","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0048","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/14728222.2021.1938541","article-title":"lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?","volume":"25","author":"Montes","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.tranon.2022.101579_bib0049","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.06.007","article-title":"The potential of liquid biopsies in gastrointestinal cancer","volume":"84","author":"Wu","year":"2020","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tranon.2022.101579_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101090","article-title":"Non-coding RNAs in pancreatic ductal adenocarcinoma: new approaches for better diagnosis and therapy","volume":"14","author":"Mortoglou","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0052","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","article-title":"lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions","volume":"75","author":"McCabe","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2020.11.007","article-title":"Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: a comparative review","volume":"37","author":"Oda","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tranon.2022.101579_bib0054","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14737159.2020.1842199","article-title":"Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers","volume":"20","author":"Abdi","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.tranon.2022.101579_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","article-title":"Circulating microRNAs: biomarkers of disease","volume":"516","author":"Wu","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tranon.2022.101579_bib0056","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/cancers10040101","article-title":"Epigenetic modifications as biomarkers of tumor development, therapy response, and recurrence across the cancer care continuum","volume":"10","author":"Thomas","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0057","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinbiochem.2019.10.002","article-title":"Prognostic urinary miRNAs for the assessment of small renal masses","volume":"75","author":"Di Meo","year":"2020","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tranon.2022.101579_bib0058","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","article-title":"Roles and mechanisms of exosomal non-coding RNAs in human health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0059","article-title":"The potential roles of exosomal non-coding RNAs in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0060","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.31931","article-title":"Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma","volume":"144","author":"Lee","year":"2019","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.tranon.2022.101579_bib0061","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01396-6","article-title":"Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications","volume":"20","author":"Tang","year":"2021","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.tranon.2022.101579_bib0062","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/ijms22115601","article-title":"The potential of Aptamer-mediated liquid biopsy for early detection of cancer","volume":"22","author":"Roy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0063","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3892\/ol.2020.11691","article-title":"Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2022.101579_bib0064","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.tranon.2022.101579_bib0065","doi-asserted-by":"crossref","first-page":"18790","DOI":"10.3390\/ijms140918790","article-title":"Long non-coding RNAs and complex human diseases","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0066","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcancer.2020.10.001","article-title":"Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma","volume":"75","author":"Sharma","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0067","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: a literature review","volume":"233","author":"Hosseinahli","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tranon.2022.101579_bib0068","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/mps4010010","article-title":"Recent advances in miRNA delivery systems","volume":"4","author":"Dasgupta","year":"2021","journal-title":"Methods Protoc."},{"key":"10.1016\/j.tranon.2022.101579_bib0069","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tranon.2022.101579_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107849","article-title":"A review of sample preparation for purification of microRNAs and analysis by mass spectrometry methods","volume":"182","author":"Salim","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.tranon.2022.101579_bib0071","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12896-018-0421-6","article-title":"Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal","volume":"18","author":"Brown","year":"2018","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.tranon.2022.101579_bib0072","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ncrna.2021.08.001","article-title":"Long non-coding RNAs in oncourology","volume":"6","author":"Gareev","year":"2021","journal-title":"Non-Coding RNA Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0073","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-016-0524-4","article-title":"Circulating long non-coding RNAs in cancer: current status and future perspectives","volume":"15","author":"Qi","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0074","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2045-3701-2-37","article-title":"Strategies to identify long noncoding RNAs involved in gene regulation","volume":"2","author":"Lee","year":"2012","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tranon.2022.101579_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15171\/bi.2016.04","article-title":"A microRNA isolation method from clinical samples","volume":"6","author":"Vahed","year":"2016","journal-title":"BioImpacts"},{"key":"10.1016\/j.tranon.2022.101579_bib0076","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","article-title":"Non-coding RNAs in cancer: platforms and strategies for investigating the genomic \u201cdark matter","volume":"39","author":"Grillone","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0077","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2022.101579_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151246","article-title":"The sequence and structure determine the function of mature human miRNAs","volume":"11","author":"Rolle","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tranon.2022.101579_bib0079","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11427-017-9199-1","article-title":"An expression atlas of miRNAs in Arabidopsis thaliana","volume":"61","author":"Xu","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.clinbiochem.2013.02.009","article-title":"miRNAs: their discovery, biogenesis and mechanism of action","volume":"46","author":"T\u00e9treault","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tranon.2022.101579_bib0081","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-019-02917-y","article-title":"MicroRNAs and child neuropsychiatric disorders: a brief review","volume":"45","author":"Paul","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0082","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/cells9071698","article-title":"Current status of microRNA-based therapeutic approaches in neurodegenerative disorders","volume":"9","author":"Paul","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tranon.2022.101579_bib0083","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13205-020-02498-6","article-title":"Human microRNAs in host\u2013parasite interaction: a review","volume":"10","author":"Paul","year":"2020","journal-title":"3 Biotech."},{"key":"10.1016\/j.tranon.2022.101579_bib0084","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s13577-021-00540-0","article-title":"Current insight into the functions of microRNAs in common human hair loss disorders: a mini review","volume":"34","author":"Paul","year":"2021","journal-title":"Hum. Cell."},{"key":"10.1016\/j.tranon.2022.101579_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biochi.2021.05.015","article-title":"Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential","volume":"187","author":"Paul","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/j.tranon.2022.101579_bib0086","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ptr.7338","article-title":"Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy","volume":"36","author":"Ruiz-Manriquez","year":"2022","journal-title":"Phyther. Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0087","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/molecules27010211","article-title":"The emerging role of MicroRNAs in bone diseases and their therapeutic potential","volume":"27","author":"Bravo V\u00e1zquez","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tranon.2022.101579_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198631","article-title":"The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: a mini-review","volume":"308","author":"Paul","year":"2022","journal-title":"Virus Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108763","article-title":"Roles of microRNAs in chronic pediatric diseases and their use as potential biomarkers: a review","volume":"699","author":"Paul","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tranon.2022.101579_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/genes13020191","article-title":"A brief review on the regulatory roles of MicroRNAs in cystic diseases and their use as potential biomarkers","volume":"13","author":"Ruiz-Manriquez","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.tranon.2022.101579_bib0091","first-page":"1","article-title":"Functional implications and clinical potential of MicroRNAs in irritable bowel syndrome: a concise review","volume":"1","author":"Bravo-V\u00e1zquez","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0092","doi-asserted-by":"crossref","first-page":"e23134","DOI":"10.1002\/jbt.23134","article-title":"Impact of smoking-induced dysregulated human miRNAs in chronic disease development and their potential use in prognostic and therapeutic purposes","volume":"36","author":"Paul","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tranon.2022.101579_bib0093","doi-asserted-by":"crossref","DOI":"10.2174\/2772270816666220606112727","article-title":"Tumor suppressor microRNAs in gastrointestinal cancers: a mini-review","volume":"16","author":"Jothimani","year":"2022","journal-title":"Recent Adv. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.tranon.2022.101579_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.910733","article-title":"MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: a mechanistic insight","volume":"13","author":"Ruiz-Manriquez","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.tranon.2022.101579_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13205-022-03343-8","article-title":"Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations","volume":"12","author":"Estrada-Meza","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.tranon.2022.101579_bib0096","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JP9.0000000000000029","article-title":"Development of microRNA-based therapy for pancreatic cancer","volume":"2","author":"Fesler","year":"2019","journal-title":"J. Pancreatol."},{"key":"10.1016\/j.tranon.2022.101579_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110799","article-title":"microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer","volume":"132","author":"Liang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2022.101579_bib0098","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.3390\/ijms20225573","article-title":"Mechanisms and functions of long non-coding RNAs at multiple regulatory levels","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0099","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: from disease code to drug role","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.tranon.2022.101579_bib0101","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.7150\/ijbs.62573","article-title":"LncRNA H19: a novel oncogene in multiple cancers","volume":"17","author":"Yang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0102","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-018-0282-x","article-title":"Long non-coding RNAs in ischemic stroke","volume":"9","author":"Bao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2022.101579_bib0103","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12885-019-5435-5","article-title":"Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues","volume":"19","author":"Esfandi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0104","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1002\/rmv.2198","article-title":"Diverse roles of long non-coding RNAs in viral diseases","volume":"31","author":"Ginn","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.tranon.2022.101579_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.665811","article-title":"Emerging role of long non-coding RNAs in diabetic vascular complications","volume":"12","author":"Tanwar","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.tranon.2022.101579_bib0106","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/biom11081132","article-title":"The emerging role of long non-coding RNAs and MicroRNAs in neurodegenerative diseases: a perspective of machine learning","volume":"11","author":"Garc\u00eda-Fonseca","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2022.101579_bib0107","doi-asserted-by":"crossref","first-page":"35684","DOI":"10.18632\/oncotarget.5533","article-title":"Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2022.101579_bib0108","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13402-016-0275-7","article-title":"Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application","volume":"39","author":"Taucher","year":"2016","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12935-020-01550-y","article-title":"Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tranon.2022.101579_bib0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0111","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2014.09.006","article-title":"miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies","volume":"81","author":"Chitkara","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tranon.2022.101579_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114357","article-title":"MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer","volume":"189","author":"Sarwar","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tranon.2022.101579_bib0113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers10040103","article-title":"Role of gene therapy in pancreatic cancer \u2013 a review","volume":"10","author":"Sato-Dahlman","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174006","article-title":"Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma","volume":"901","author":"Lotfi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tranon.2022.101579_bib0115","doi-asserted-by":"crossref","unstructured":"M.V. Martinez-Dominguez, A. Zottel, N. \u0160amec, I. Jov\u010devska, C. Dincer, U.D. Kahlert, A.C. Nickel, Current technologies for RNA-directed liquid diagnostics, Cancers (Basel). 13 (2021) 5060. 10.3390\/cancers13205060.","DOI":"10.3390\/cancers13205060"},{"key":"10.1016\/j.tranon.2022.101579_bib0116","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.tranon.2022.101579_bib0117","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/cancers13112680","article-title":"MicroRNA therapeutics in cancer: current advances and challenges","volume":"13","author":"Reda El Sayed","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0118","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000001826","article-title":"MicroRNAs as potential therapeutic targets for pancreatic cancer","volume":"135","author":"Chu","year":"2022","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.tranon.2022.101579_bib0119","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/cam4.2145","article-title":"Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis","volume":"8","author":"Zou","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0120","first-page":"1601","article-title":"A seven\u2011miRNA expression\u2011based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer","volume":"18","author":"Bai","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0121","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.7150\/jca.38048","article-title":"Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer","volume":"11","author":"Wei","year":"2020","journal-title":"J. Cancer."},{"key":"10.1016\/j.tranon.2022.101579_bib0122","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fbioe.2020.00379","article-title":"The serum MicroRNA signatures for pancreatic cancer detection and operability evaluation","volume":"8","author":"Yan","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tranon.2022.101579_bib0123","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1038\/s41598-020-64569-1","article-title":"Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods","volume":"10","author":"Shams","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0124","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/ijms22031007","article-title":"Identification of circulating serum miRNAs as novel biomarkers in pancreatic cancer using a penalized algorithm","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0125","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s10528-021-10062-x","article-title":"An integrated data analysis of mRNA, miRNA and signaling pathways in pancreatic cancer","volume":"59","author":"Sohrabi","year":"2021","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.tranon.2022.101579_bib0126","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1245\/s10434-020-09440-3","article-title":"MicroRNA-593-3p expression in peritoneal lavage fluid as a prognostic marker for pancreatic cancer patients undergoing staging laparoscopy","volume":"28","author":"Hata","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biocel.2019.01.020","article-title":"MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5","volume":"111","author":"Wang","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0128","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-019-1105-3","article-title":"MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12","volume":"38","author":"He","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111543","article-title":"Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer","volume":"383","author":"Fang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.7150\/thno.38327","article-title":"Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2022.101579_bib0131","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2022.101579_bib0132","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/biom11050639","article-title":"Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels","volume":"11","author":"Panebianco","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2022.101579_bib0133","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-021-04289-z","article-title":"MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism","volume":"88","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tranon.2022.101579_bib0134","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s10620-019-05911-0","article-title":"Inhibition of TUG1\/miRNA-299-3p axis represses pancreatic cancer malignant progression via suppression of the Notch1 pathway","volume":"65","author":"Xu","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117857","article-title":"Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis","volume":"255","author":"Wu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0136","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.18632\/aging.202569","article-title":"Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN\/AKT pathway","volume":"13","author":"Cao","year":"2021","journal-title":"Aging (Albany. NY)."},{"key":"10.1016\/j.tranon.2022.101579_bib0137","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.7150\/jca.48418","article-title":"MiR-146b-3p regulates proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10","volume":"12","author":"Zhou","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0138","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10565-021-09597-x","article-title":"microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3","volume":"38","author":"Chang","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tranon.2022.101579_bib0139","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jcmm.14766","article-title":"Pancreatic cancer cell\u2013derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2","volume":"24","author":"Shang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2021.01.018","article-title":"miR24\u20133p activity after delivery into pancreatic carcinoma cell lines exerts profound tumor-inhibitory effects through distinct pathways of apoptosis and autophagy induction: miR24 in pancreatic cancer","volume":"503","author":"Borchardt","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2022.101579_bib0141","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.7150\/jca.34902","article-title":"MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-\u03b2 signaling pathway","volume":"11","author":"Chen","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0142","article-title":"Baicalein induces apoptosis of pancreatic cancer cells by regulating the expression of miR-139-3p and miR-196b-5p","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0143","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1080\/21655979.2021.1956404","article-title":"The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions","volume":"12","author":"Long","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.tranon.2022.101579_bib0144","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3892\/or.2021.8223","article-title":"MicroRNA-190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4","volume":"47","author":"Li","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.gastro.2021.09.029","article-title":"miR-802 suppresses acinar-to-ductal reprogramming during early pancreatitis and pancreatic carcinogenesis","volume":"162","author":"Ge","year":"2022","journal-title":"Gastroenterology."},{"key":"10.1016\/j.tranon.2022.101579_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119933","article-title":"Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance","volume":"284","author":"Raei","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0147","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","article-title":"LncRNAs in cancer: regulatory and therapeutic implications","volume":"501","author":"Nandwani","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2022.101579_bib0148","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1186\/s12885-020-07470-4","article-title":"Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer","volume":"20","author":"Zu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0149","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/biom11111665","article-title":"LncRNAs: novel biomarkers for pancreatic cancer","volume":"11","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.tranon.2022.101579_bib0150","article-title":"Long Non-coding RNA DLEU2L targets miR-210-3p to suppress gemcitabine resistance in pancreatic cancer cells via BRCA2 regulation","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tranon.2022.101579_bib0151","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.18632\/aging.203251","article-title":"lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany. NY)."},{"key":"10.1016\/j.tranon.2022.101579_bib0152","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2022.101579_bib0153","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13578-019-0290-2","article-title":"LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p","volume":"9","author":"Cheng","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tranon.2022.101579_bib0154","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/2211-5463.12732","article-title":"LncRNA DANCR promotes proliferation and metastasis in pancreatic cancer by regulating miRNA-33b","volume":"10","author":"Luo","year":"2020","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.tranon.2022.101579_bib0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200805","article-title":"LncRNA SNHG12 contributes proliferation, invasion and epithelial\u2013mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b","volume":"40","author":"Cao","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0156","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41417-020-00213-4","article-title":"LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway","volume":"28","author":"Qu","year":"2021","journal-title":"Cancer Gene. Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0157","article-title":"m6A-mediated upregulation of LINC00857 promotes pancreatic cancer tumorigenesis by regulating the miR-150-5p\/E2F3 axis","volume":"11","author":"Meng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0158","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3748\/wjg.v27.i17.1993","article-title":"Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p\/GOLM1 axis","volume":"27","author":"Wang","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2022.101579_bib0159","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/or.2021.8010","article-title":"LncRNA GATA3-AS1-miR-30b-5p-Tex10 axis modulates tumorigenesis in pancreatic cancer","volume":"45","author":"Liu","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/15384047.2021.1883184","article-title":"LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p\/KIAA1522 axis","volume":"22","author":"Lin","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0161","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-021-03921-3","article-title":"LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2022.101579_bib0162","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12967-021-03052-5","article-title":"Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition","volume":"19","author":"Ma","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tranon.2022.101579_bib0163","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.omtn.2021.08.024","article-title":"LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K\/AKT pathway","volume":"26","author":"Luo","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tranon.2022.101579_bib0164","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/or.2021.8232","article-title":"FGD5\u2011AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt\/\u03b2\u2011catenin signaling pathway via miR\u2011577","volume":"47","author":"Zhang","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jmcb\/mjab042","article-title":"A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1\u03b1 in pancreatic cancer","volume":"13","author":"Zhu","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0166","article-title":"LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a\/CDKN2D axis","volume":"14","author":"Zhu","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0167","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12935-021-02189-z","article-title":"LncRNA MIR99AHG mediated by FOXA1 modulates NOTCH2\/Notch signaling pathway to accelerate pancreatic cancer through sponging miR-3129-5p and recruiting ELAVL1","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tranon.2022.101579_bib0168","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4125432","article-title":"Effects of lncRNA LINC01320 on proliferation and migration of pancreatic cancer cells through targeted regulation of miR-324-3p","volume":"2021","author":"Meng","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"10.1016\/j.tranon.2022.101579_bib0169","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1002\/jcp.27372","article-title":"Melatonin and pancreatic cancer: current knowledge and future perspectives","volume":"234","author":"Tamtaji","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tranon.2022.101579_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10528-021-10104-4","article-title":"Potential therapeutic effects of melatonin mediate via miRNAs in cancer","volume":"60","author":"Pourmohammad","year":"2022","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.tranon.2022.101579_bib0171","series-title":"Natural Products and Human Diseases Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-3-030-73234-9_31","article-title":"Antitumor and protective effects of melatonin: the potential roles of MicroRNAs","author":"Ashrafizadeh","year":"2021"},{"key":"10.1016\/j.tranon.2022.101579_bib0172","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/cbdd.13849","article-title":"Multiple interactions between melatonin and non-coding RNAs in cancer biology","volume":"98","author":"Maleki","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tranon.2022.101579_bib0173","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.657965","article-title":"Regulation of hippo, TGF\u03b2\/SMAD, Wnt\/\u03b2-Catenin, JAK\/STAT, and NOTCH by long non-coding RNAs in pancreatic cancer","volume":"11","author":"Farooqi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0174","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109521","article-title":"Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine","volume":"121","author":"Dai","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2022.101579_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tranon.2022.101579_bib0176","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.omto.2020.10.003","article-title":"Regulation of Glycolysis by Non-coding RNAs in cancer: switching on the warburg effect","volume":"19","author":"Mirzaei","year":"2020","journal-title":"Mol. Ther. Oncolytics."},{"key":"10.1016\/j.tranon.2022.101579_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144158","article-title":"Crucial players in glycolysis: cancer progress","volume":"726","author":"Abbaszadeh","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.tranon.2022.101579_bib0178","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1080\/15384101.2020.1796036","article-title":"Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p","volume":"19","author":"Ma","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2022.101579_bib0179","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.7150\/jca.43379","article-title":"MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41467-019-08759-0","article-title":"MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2022.101579_bib0181","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.539805","article-title":"LncRNA-BLACAT1 facilitates proliferation, migration and aerobic glycolysis of pancreatic cancer cells by repressing CDKN1C via EZH2-Induced H3K27me3","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0182","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.omtn.2021.07.004","article-title":"LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway","volume":"26","author":"Xu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tranon.2022.101579_bib0183","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1080\/15476286.2021.1930755","article-title":"MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p\/HK2\/PKM2 axis","volume":"18","author":"Yu","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0184","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.625056","article-title":"MicroRNA-505, suppressed by oncogenic long non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101343","article-title":"Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer","volume":"17","author":"Wirth","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0186","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188461","article-title":"Therapeutic resistance of pancreatic cancer: roadmap to its reversal","volume":"1875","author":"Yu","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tranon.2022.101579_bib0187","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/cancers11070900","article-title":"miRNA predictors of pancreatic cancer chemotherapeutic response: a systematic review and meta-analysis","volume":"11","author":"Madurantakam Royam","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2022.101579_bib0188","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.semcancer.2020.11.004","article-title":"Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer","volume":"83","author":"Xie","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0189","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7946431","article-title":"The microbiota and immune system crosstalk in health and disease","volume":"2018","author":"Pagliari","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.tranon.2022.101579_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","article-title":"The microbiota and microbiome in pancreatic cancer: more influential than expected","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.tranon.2022.101579_bib0191","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPA.0000000000001744","article-title":"The unique microbiome and immunity in pancreatic cancer","volume":"50","author":"Wei","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.tranon.2022.101579_bib0192","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/carcin\/bgaa013","article-title":"The potential role of bacteria in pancreatic cancer: a systematic review","volume":"41","author":"Li","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tranon.2022.101579_bib0193","article-title":"A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma","author":"Pandya","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2022.101579_bib0194","doi-asserted-by":"crossref","first-page":"40295","DOI":"10.18632\/oncotarget.5641","article-title":"Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model","volume":"6","author":"Rachagani","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2022.101579_bib0195","article-title":"Deliver the promise: rNAs as a new class of molecular entities for therapy and vaccination","author":"Yu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0196","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1566523219666190719100526","article-title":"Current RNA-based therapeutics in clinical trials","volume":"19","author":"Zhou","year":"2019","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.tranon.2022.101579_bib0197","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1002\/jcp.30333","article-title":"MicroRNAs in the interaction between host\u2013bacterial pathogens: a new perspective","volume":"236","author":"Riahi Rad","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tranon.2022.101579_bib0198","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/1568026621666210303150235","article-title":"Therapeutic potential of microRNA against Th2-associated immune disorders","volume":"21","author":"Kumar","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tranon.2022.101579_bib0199","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-019-0748-z","article-title":"Noncoding RNAs in cancer therapy resistance and targeted drug development","volume":"12","author":"Wang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2022.101579_bib0200","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.3748\/wjg.v27.i24.3568","article-title":"Room for improvement in the treatment of pancreatic cancer: novel opportunities from gene targeted therapy","volume":"27","author":"Galanopoulos","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2022.101579_bib0201","doi-asserted-by":"crossref","first-page":"17650","DOI":"10.1038\/s41598-018-35974-4","article-title":"Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity","volume":"8","author":"Rounge","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2022.101579_bib0202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/epi-2020-0289","article-title":"The influence of lifestyle factors on miRNA expression and signal pathways: a review","volume":"13","author":"Panico","year":"2021","journal-title":"Epigenomics"},{"key":"10.1016\/j.tranon.2022.101579_bib0203","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics \u2013 challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322002388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322002388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:25:06Z","timestamp":1761845106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523322002388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":203,"alternative-id":["S1936523322002388"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101579","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101579"}}